Mendus AB: Mendus to receive final payment as a result of the completion of the EU Horizon 2020 AML-VACCiN project
October 12, 2022 02:00 ET
|
Mendus AB
HORIZON 2020 GRANT SUPPORTED MENDUS IN ESTABLISHING A STRONG EUROPEAN RESEARCH AND CLINICAL NETWORK FOR THE DEVELOPMENT OF DCP-001 IN AML Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical...
Mendus AB: Mendus erhåller slutbetalning som ett resultat av EU Horizon 2020 AML-VACCiN-projektets slutförande
October 12, 2022 02:00 ET
|
Mendus AB
HORIZON 2020 BEVILJADE STÖD FÖR MENDUS ATT ETABLERA ETT STARKT EUROPEISKT FORSKNINGS- OCH KLINISKT NÄTVERK FÖR UTVECKLING AV DCP-001 I AML Mendus AB (“Mendus” publ; IMMU.ST), ett...
Merck Recognized for Responsible Entrepreneurship in the Netherlands
May 19, 2022 15:39 ET
|
Embassy of the Kingdom of the Netherlands
Washington, D.C., May 19, 2022 (GLOBE NEWSWIRE) -- On May 19, the Embassy of the Kingdom of the Netherlands presented the 2022 Holland on the Hill Heineken Award to New Jersey-based...
Immunicum meddelar lovande resultat avseende överlevnad i fas II-studien MERECA med ilixadencel i njurcancer
February 22, 2021 02:00 ET
|
Immunicum AB
Pressmeddelande 22 februari 2021 Immunicum meddelar lovande resultat avseende överlevnad i fas II-studien MERECA med ilixadencel i njurcancer - Medianöverlevnad för patientgruppen som behandlades...
Immunicum Announces Encouraging Signs of Survival Benefit in Phase II MERECA Trial of Ilixadencel in Kidney Cancer
February 22, 2021 02:00 ET
|
Immunicum AB
Press Release 22 February 2021 Immunicum Announces Encouraging Signs of Survival Benefit in Phase II MERECA Trial of Ilixadencel in Kidney Cancer -- Median Overall Survival (OS) for the...
Immunicum AB (publ) planerar att expandera bolagets anläggning för forskning och processutveckling i Leiden, Nederländerna
January 27, 2021 02:00 ET
|
Immunicum AB
27 januari 2021 Immunicum AB (publ) planerar att expandera bolagets anläggning för forskning och processutveckling i Leiden, Nederländerna Immunicum AB (publ; IMMU.ST) meddelar idag att de...
Immunicum AB (publ) Plans to Expand its Research and Process Development Facilities in Leiden, the Netherlands
January 27, 2021 02:00 ET
|
Immunicum AB
Press Release 27 January 2021 Immunicum AB (publ) Plans to Expand its Research and Process Development Facilities in Leiden, the Netherlands Immunicum AB (publ; IMMU.ST) announced today that...
ValueSelling Associates Welcomes Sales Industry Expert Bart van Eijck
September 17, 2020 14:50 ET
|
ValueSelling Associates, Inc.
RANCHO SANTA FE, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) -- ValueSelling Associates, Inc. announces its partnership with Bart van Eijck to expand the reach of ValueSelling’s sales training and sales...
Dutch Embassy Recognizes the Rosie the Riveter with "A Ringing Tribute to Honor the Rosies"
September 03, 2020 17:12 ET
|
Embassy of the Kingdom of the Netherlands
Washington, D.C., Sept. 03, 2020 (GLOBE NEWSWIRE) -- As the Kingdom of the Netherlands commemorates the end of World War II and celebrates 75 years of freedom, the Dutch Embassy today recognized...
Telix Pharmaceuticals and PI Medical Sign Distribution Agreement for the Netherlands
July 01, 2019 20:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and RAAMSDONKSVEER, Netherlands, July 02, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company...